- Ticker
- ACON
- Price
- 0.30
- Stock movement up
- +0.03 (11.84%)
- Company name
- Aclarion Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Health Information Services
- Market cap
- 2.34M
- Ent value
- 2.28M
- Price/Sales
- 38.69
- Price/Book
- 1.31
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -7.51%
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -63.72%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2023-11-21
Get the latest news and real-time alerts from Aclarion, Inc. (ACON) stock at Seeking Alpha.
June 8, 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Aclarion, Inc. (ACON) stock at Seeking Alpha.
May 19, 2023
iO Charts is a Seeking Alpha partner
DIVIDENDS
ACON does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 38.69 |
| Price to Book | 1.31 |
| EV to Sales | 37.79 |
Get the latest news and real-time alerts from Aclarion, Inc. (ACON) stock at Seeking Alpha.
April 24, 2023
iO Charts is a Seeking Alpha partner
Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week
May 14, 2022
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 7.86M |
| EPS (TTM) | -0.97 |
| FCF per share (TTM) | -0.71 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 60.44K |
| Gross profit (TTM) | -4.85K |
| Operating income (TTM) | -6.10M |
| Net income (TTM) | -7.61M |
| EPS (TTM) | -0.97 |
| EPS (1y forward) | -0.38 |
Margins
Loading...
Margins data
| Gross margin (TTM) | -8.03% |
| Operating margin (TTM) | -10090.85% |
| Profit margin (TTM) | -12582.79% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 1.47M |
| Net receivables | 18.57K |
| Total current assets | 1.99M |
| Goodwill | 0.00 |
| Intangible assets | 1.21M |
| Property, plant and equipment | 0.00 |
| Total assets | 3.21M |
| Accounts payable | 457.56K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 1.42M |
| Total liabilities | 1.42M |
| Shareholder's equity | 1.79M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -5.31M |
| Capital expenditures (TTM) | 219.57K |
| Free cash flow (TTM) | -5.53M |
| Dividends paid (TTM) | 415.52K |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -425.42% |
| Return on Assets | -237.23% |
| Return on Invested Capital | -425.42% |
| Cash Return on Invested Capital | -309.54% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.27 |
| Daily high | 0.33 |
| Daily low | 0.25 |
| Daily Volume | 395K |
| All-time high | 2.72 |
| 1y analyst estimate | 3.00 |
| Beta | - |
| EPS (TTM) | -0.97 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 28 Feb 2024 |
Downside potential
Loading...
Downside potential data
| ACON | S&P500 | |
| Current price drop from All-time high | -89.06% | -5.12% |
| Highest price drop | -90.22% | -56.47% |
| Date of highest drop | 20 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -69.86% | -11.48% |
| Avg time to new high | 400 days | 13 days |
| Max time to new high | 399 days | 1805 days |
Aclarion has filed to raise $48M from the sale of stock and warrants in a US IPO. Aclarion is developing improved medical imaging technologies. Read more here.
March 4, 2022
iO Charts is a Seeking Alpha partner
Aclarion is advancing its SaaS technology for the non-invasive and non-provocative diagnosis of pain-causing spinal discs leveraging MRS data. Read more here.
January 18, 2022
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
2.34M
Marketcap category
Small-cap
Description
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. The company develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in Broomfield, Colorado.
Employees
7
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner